Reinhart Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-355,139
Closed -$7.5M 82
2019
Q4
$7.5M Buy
355,139
+160,837
+83% +$3.26M 0.55% 63
2019
Q3
$3.8M Buy
194,302
+910
+0.5% +$16.7K 0.35% 63
2019
Q2
$3.37M Buy
193,392
+36,468
+23% +$657K 0.3% 68
2019
Q1
$2.9M Buy
156,924
+34,389
+28% +$613K 0.27% 66
2018
Q4
$1.97M Sell
122,535
-11,795
-9% -$187K 0.21% 70
2018
Q3
$2M Buy
134,330
+11,510
+9% +$168K 0.18% 66
2018
Q2
$1.72M Buy
122,820
+10,450
+9% +$138K 0.17% 62
2018
Q1
$1.46M Buy
112,370
+2,220
+2% +$28.4K 0.15% 61
2017
Q4
$1.52M Buy
110,150
+1,030
+0.9% +$13.9K 0.15% 65
2017
Q3
$1.43M Hold
109,120
0.15% 64
2017
Q2
$1.4M Buy
+109,120
New +$1.45M 0.14% 67

Other funds holding MPT

Reinhart Partners's MPT Position: Q1 2020 in Review

Reinhart Partners sold out of Medical Properties Trust (MPT) in Q1 2020, closing a stake of 355,139 shares — an estimated $7.5M sold.

Reinhart Partners first reported a position in MPT in Q2 2017 and held it in 11 quarters. The position peaked at $7.5M in Q4 2019. 495 funds tracked by Wall St. Rank hold MPT as of Q1 2020.

  • Reinhart Partners reported no remaining Medical Properties Trust position as of Q1 2020 after selling out during the quarter.
  • Reinhart Partners sold 355,139 Medical Properties Trust shares in Q1 2020, an estimated $7.5M.
  • Reinhart Partners first reported a position in Medical Properties Trust in Q2 2017 and held it in 11 quarters.
  • Reinhart Partners's Medical Properties Trust position peaked at $7.5M in Q4 2019.
  • 495 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2020.

Based on Reinhart Partners's 13F filing for Q1 2020, filed 23 Apr 2020.